Skip to main content
. 2005 Nov 14;11(42):6607–6612. doi: 10.3748/wjg.v11.i42.6607

Table 3.

Comparison of the result of different tumor markers between HCC and non-HCC group

Tumor marker (cut-off point) Sensitivity Specificity
% %
AFP (10 ng/mL) 86 78
PIVKA-II (35 mAU/L) 61 72
KL-6 (500 U/L) 34 80
AFP+PIVKA-II 861 93
AFP+KL-6 872 94
AFP+PIVKA-II+KL-6 87 99
1

All PIVKA-II (+) HCC patients are AFP (+).

2

One KL-6 (+) HCC patient is AFP (–).